Academician
PINAR KUL KARADENİZLİ
ARAŞTIRMA GÖREVLİSİ
ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
A quick look at recorded outputs — details below.
- Articles 5
- Projects 0
- Books 0
- Proceedings 3
- Patents 0
- Artistic 0
Scopus (SJR)
Q1
1
Q2
2
Q3
4
Q4
0
WoS (JCR)
Q1
1
Q2
1
Q3
5
Q4
0
TR Index
1
articles
Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.
Top 1% articles
0
Top 10% articles
0
Avg percentile
53.4%
Top 1% share
0.0%
Top 10% share
0.0%
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Article list
- 2024 Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.9%
- 2023 A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.7%
- 2022 Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.3%
- 2026 Biological evaluation of novel 6,9-disubstituted purine analogues in high-grade serous ovarian cancer cell lines YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 15.5%
- 2026 Synthesis and biological evaluation of 6,9-disubstituted purine analogues inducing autophagy-mediated apoptosis and potentiating carboplatin response in high-grade serous ovarian cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.7%
- 2023 Incorporation of Protecting Groups in Organic Chemistry: A Mini-Review YÖKSİS SJR Q3 JCR Q3 OpenAlex 52.3%
- 2023 A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition YÖKSİS SJR Q3 JCR Q3 OpenAlex 54.7%